1. Powles RL, Clink HM, Spence D, Morgenstern G, Watson JG, Selby HJ et al. Cyclosporine A to prevent graft-versus-host disease in man after allogeneic bone marrow transplantation. Lancet 1980; 1: 327–329.
2. Laszik Z, Silva F . Hemolytic-uremic syndrome, thrombotic thrombocytopenic purpura, and systemic sclerosis (systemic scleroderma). In: Jennet JC, Olson JL, Schwartz MM, Silva FG (eds). Heptinstall's Pathology of the Kidney. Lippincott-Raven: Philadelphia, 1998, pp 1003–1057.
3. Sadler JE, Poncz M . Antibody-mediated thrombotic disorders: idiopathic thrombotic thrombocytopenic purpura and heparin-induced thrombocytopenia. In: Lichtman MA, Beutler E, Kipps TJ, Seligsohn U, Kaushansky K, Prchal J (eds). Williams Hematology. McGraw-Hill: New York, 2006, pp 2031–2054.
4. George JN, Li X, McMinn JR, Terrell DR, Vesely SK, Selby GB . Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic hematopoietic stem cell transplantation: a diagnostic dilemma. Transfusion 2004; 44: 294–304.
5. Daly AS, Xenocostas A, Lipton JH . Transplantation-associated thrombotic microangiopathy: twenty-two years later. Bone Marrow Transplant 2002; 30: 709–715.